Skip to main content

Gilead Sciences Invests in Research for COVID-19 Treatments for All Ages

By: 3BL Media

SOURCE: Gilead Sciences

DESCRIPTION:

Children are being hospitalized with COVID 19 at increasingly high rates, and those younger than 5 aren't eligible to receive a vaccine. We’re committed to helping in this area by investing in research for COVID-19 treatments for all ages.

About Gilead Sciences
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

Originally published by Gilead Sciences.

Tweet me: .@GileadSciences is committed to helping children being hospitalized with #COVID19 by investing in research for COVID-19 treatments for all ages. #CROI2022 https://bit.ly/3GNxutP

KEYWORDS: NASDAQ: GILD, COVID-19, CROI2022

Chart showing increase in COVID-19 hospitalizations among children in the US

Recent Quotes

View More
Symbol Price Change (%)
AMZN  209.56
+4.70 (2.29%)
AAPL  263.44
+2.86 (1.10%)
AMD  199.88
-3.49 (-1.72%)
BAC  52.98
+0.21 (0.40%)
GOOG  315.57
+12.01 (3.96%)
META  655.00
+10.22 (1.58%)
MSFT  396.70
-1.76 (-0.44%)
NVDA  189.53
+1.63 (0.87%)
ORCL  147.68
-8.86 (-5.66%)
TSLA  410.02
-1.69 (-0.41%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.